Flossbach Von Storch Portfolio holdings
AUM
$24.5B
This Quarter Return
+5.1%
1 Year Return
+15.02%
3 Year Return
+53.12%
5 Year Return
+64.59%
10 Year Return
+174.12%
AUM
$9.52B
AUM Growth
+$9.52B
(+9.1%)
Cap. Flow
+$363M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
59.39%
Holding
103
New
8
Increased
26
Reduced
40
Closed
7
Top Buys
| 1 |
Philip Morris
PM
|
$327M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$176M |
| 3 |
Booking.com
BKNG
|
$156M |
| 4 |
WP
Worldpay, Inc.
WP
|
$148M |
| 5 |
Danaher
DHR
|
$85.3M |
Top Sells
| 1 |
Amgen
AMGN
|
$181M |
| 2 |
Nike
NKE
|
$141M |
| 3 |
Abbott
ABT
|
$136M |
| 4 |
Coca-Cola
KO
|
$111M |
| 5 |
Fortive
FTV
|
$70.1M |
Sector Composition
| 1 | Consumer Discretionary | 21.23% |
| 2 | Healthcare | 16.67% |
| 3 | Financials | 15.12% |
| 4 | Materials | 14.18% |
| 5 | Communication Services | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Yum! Brands
YUM
$40.8B
| $766K | 0.01% | 10,400 | – | – |
|
77
Credicorp
BAP
$20.4B
| $718K | 0.01% | 3,500 -3,500 | -50% | -$718K |
|
78
NetEase
NTES
$86.2B
| $396K | ﹤0.01% | +1,500 | New | +$396K |
|
79
Mercado Libre
MELI
$125B
| $388K | ﹤0.01% | +1,500 | New | +$388K |
|
80
Gilead Sciences
GILD
$140B
| $293K | ﹤0.01% | 3,620 | – | – |
|
81
Dr. Reddy's Laboratories
RDY
$11.8B
| $285K | ﹤0.01% | 8,000 -26,000 | -76% | -$926K |
|
82
APA Corp
APA
$8.31B
| $209K | ﹤0.01% | +4,553 | New | +$209K |
|
|
DISCA
83
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $208K | ﹤0.01% | +9,780 | New | +$208K |
|
84
Automatic Data Processing
ADP
$123B
| – | – | -6,800 | Closed | -$697K |
|
85
Expedia Group
EXPE
$26.6B
| – | – | 0 | – | – |
|
|
86
Alphabet (Google) Class C
GOOG
$2.58T
| – | – | -1,000 | Closed | -$909K |
|
87
Honeywell
HON
$139B
| – | – | -2,500 | Closed | -$333K |
|
88
PepsiCo
PEP
$204B
| – | – | -21,700 | Closed | -$2.51M |
|
89
Qiagen
QGEN
$10.1B
| – | – | -114,175 | Closed | -$3.8M |
|
|
SPLS
90
DELISTED
Staples Inc
SPLS
| – | – | -13,530 | Closed | -$136K |
|
91
Pfizer
PFE
$141B
| – | – | -28,390 | Closed | -$954K |
|